Document is current

Article History

Received: 7 May 2023

Accepted: 6 September 2023

First Online: 14 September 2023

Competing interests

: Dr. Golbus receives funding from the NIH (L30HL143700, 1K23HL168220-01) and receives salary support by an American Heart Association grant (grant number 20SFRN35370008). Dr. Nallamothu is a principal investigator or co-investigator on research grants from the NIH, VA HSR&D and the American Heart Association. He also receives compensation as Editor-in-Chief of Circulation: Cardiovascular Quality & Outcomes, a journal of the American Heart Association. Finally, he is a co-inventor on U.S. Utility Patent Number US15/356,012 (US20170148158A1) entitled “Automated Analysis of Vasculature in Coronary Angiograms” that uses software technology with signal processing and machine learning to automate the reading of coronary angiograms, held by the University of Michigan. The patent is licensed to AngioInsight, Inc., in which Dr. Nallamothu holds ownership shares and receives consultancy fees. Dr. Sachin Kheterpal is a principal investigator or co-investigator on research grants from the US NIH, Blue Cross Blue Shield of Michigan, the American Heart Association, Apple, Merck & Co, and Becton Dickinson & Company; and is a co-inventor on US patent number 62/791,257 entitled “Automated System To Medical Procedures”, which is held by the University of Michigan. Dr. Klasnja is a principal investigator or a co-investigator on research grants from NIH. Dr. Murphy is a principal investigator or a co-investigator on research grants from NIH. Dr. Vik Kheterpal is a Principal and employee of CareEvolution. Mr. Taralunga is a Software Architect employed by CareEvolution.